We are a Public Benefit Biotech company with a mandate to develop therapies and diagnostics for the 90% of patients without adequate care, at a sustainable cost. We meet our mandate by capturing the medical impact potential in repurposed, reformulated and re-considered drugs that have pre-existing, solid safety data. We then carry out lean and efficient development, manufacturing, and distribution with likeminded partner companies to enable ethical pricing for our products. Our team brings together seasoned drug developers, entrepreneurs and inventors, people and companies with a commitment to running a thriving business serving the public health. Our mission requires us to innovate every aspect of running a pharmaceutical business – from formulating a new financial model yielding a profit balanced portfolio, to reducing research costs, to collaborating rather than competing, and utilizing alternative distribution channels. We are leading the charge for a new “Public Benefit Pharmaceutical” industry, where affordability and medical impact are the standards.